YMI: YM Biosciences, Inc. (YMI on AMEX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : YMI: YM Biosciences, Inc. (YMI on AMEX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: John McCarthy	9/19/2009 12:40:47 AM
	of 66

Severe skin reaction secondary to concomitant radiotherapy plus cetuximab Bernhard Berger and Claus Belka Department of Radiation Oncology, University of Tübingen, Hoppe-Seyler-Str. 3, 72076 Tübingen, Germany author email corresponding author email Radiation Oncology 2008, 3:5doi:10.1186/1748-717X-3-5 The electronic version of this article is the complete one and can be found online at: http ro-journal.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next